Implantation of electromagnetic transponders following radical prostatectomy for delivery of IMRT

Canadian Journal of Urology

Volumn 17, Issue 5, 2010, Pages 5365-5369

  Canter, Daniel ^a   Greenberg, Richard E ^a   Horwitz, Eric M ^a   Kutikov, Alexander ^a   Li, Jinsheng ^a   Long, Christopher ^a   Buyyounouski, Mark ^a   Boorjian, Stephen A ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Adjuvant radiation; Calypso transponders; Prostate cancer; Radical prostatectomy; Salvage radiation

Indexed keywords

ADJUVANT THERAPY; AGED; ARTICLE; FIDUCIAL MARKER; HUMAN; INSTRUMENTATION; INTENSITY MODULATED RADIATION THERAPY; MALE; METHODOLOGY; MIDDLE AGED; PROSTATE TUMOR; PROSTATECTOMY; RADIOFREQUENCY RADIATION; SALVAGE THERAPY;

AGED; FIDUCIAL MARKERS; HUMANS; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIO WAVES; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED; SALVAGE THERAPY;

EID: 79952277300     PISSN: 11959479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Ward JF, Blute ML, Slezak J, Bergstralh EJ, Zincke H. The longterm clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy. J Urol 2003;170(5):1872-1876.
2. Bott SR, Freeman AA, Stenning S, Cohen J, Parkinson MC. Radical prostatectomy: pathology findings in 1001 cases compared with other major series and over time. BJU Int 2005;95(1):34-39.
3. Han M, Partin AW, Pound CR, Epstein JI, Walsh PC. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 2001;28(3):555-565.
4. Ward JF, Moul JW. Rising prostate-specific antigen after primary prostate cancer therapy. Nat Clin Pract Urol 2005;2(4):174-182.
5. Bolla M, van Poppel H, Collette L et al. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 2005;366(9485):572-578.
6. Thompson IM, Jr, Tangen CM, Paradelo J et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. JAMA 2006;296(19):2329-2335.
7. Swanson GP, Goldman B, Tangen CM et al. The prognostic impact of seminal vesicle involvement found at prostatectomy and the effects of adjuvant radiation: data from Southwest Oncology Group 8794. J Urol 2008;180(6):2453-2457;discussion 8.
8. Trock BJ, Han M, Freedland SJ et al. Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy. JAMA 2008;299(23):2760-2769.
9. Langen KM, Jones DT. Organ motion and its management. Int J Radiat Oncol Biol Phys 2001;50(1):265-278.
10. Ten Haken RK, Forman JD, Heimburger DK et al. Treatment planning issues related to prostate movement in response to differential filling of the rectum and bladder. Int J Radiat Oncol Biol Phys 1991;20(6):1317-1324.
11. Balter JM, Wright JN, Newell LJ et al. Accuracy of a wireless localization system for radiotherapy. Int J Radiat Oncol Biol Phys 2005;61(3):933-937.
12. Kupelian P, Willoughby T, Mahadevan A et al. Multiinstitutional clinical experience with the Calypso System in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy. Int J Radiat Oncol Biol Phys 2007;67(4):1088-1098.
13. Schiffner DC, Gottschalk AR, Lometti M et al. Daily electronic portal imaging of implanted gold seed fiducials in patients undergoing radiotherapy after radical prostatectomy. Int J Radiat Oncol Biol Phys 2007;67(2):610-619.
14. Schallenkamp JM, Herman MG, Kruse JJ, Pisansky TM. Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging. Int J Radiat Oncol Biol Phys 2005;63(3):800-811.
15. rd. Prostate immobilization using a rectal balloon. J Appl Clin Med Phys 2002;3(1):6-11.
16. Litzenberg D, Dawson LA, Sandler H et al. Daily prostate targeting using implanted radiopaque markers. Int J Radiat Oncol Biol Phys 2002;52(3):699-703.
17. Willoughby TR, Kupelian PA, Pouliot J et al. Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer. Int J Radiat Oncol Biol Phys 2006;65(2):528-534.
18. Wu J, Haycocks T, Alasti H et al. Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers. Radiother Oncol 2001;61(2):127-133.
19. Nederveen A, Lagendijk J, Hofman P. Detection of fiducial gold markers for automatic on-line megavoltage position verification using a marker extraction kernel (MEK). Int J Radiat Oncol Biol Phys 2000;47(5):1435-1442.
20. Alasti H, Petric MP, Catton CN, Warde PR. Portal imaging for evaluation of daily on-line setup errors and off-line organ motion during conformal irradiation of carcinoma of the prostate. Int J Radiat Oncol Biol Phys 2001;49(3):869-884.
21. Vigneault E, Pouliot J, Laverdiere J, Roy J, Dorion M. Electronic portal imaging device detection of radioopaque markers for the evaluation of prostate position during megavoltage irradiation: a clinical study. Int J Radiat Oncol Biol Phys 1997;37(1):205-212.
22. rd. Daily electronic portal imaging for morbidly obese men undergoing radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2004;59(1):6-10.
23. Chinnaiyan P, Tomee W, Patel R, Chappell R, Ritter M. 3Dultrasound guided radiation therapy in the post-prostatectomy setting. Technol Cancer Res Treat 2003;2(5):455-458.
24. Kruse JJ, Herman MG, Hagness CR et al. Daily monitoring of patient setup variation and prostatic fossa tissue motion with an electronic portal imagind device (abstract). Int J Radiat Oncol Biol Phys 2001;51:387.